Yoshio Matsuda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yoshio Matsuda has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
Masaki Ogawa
Department of Obstetrics and Gynecology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
4 shared publicationsShoji Satoh
Maternal and Perinatal Care Center, Oita Prefectural Hospital, Oita, Japan
4 shared publicationsAkihito Nakai
Japanese Organization of Prevention of Preterm Delivery (JOPP) Tokyo Japan
3 shared publications- Ikuno Kawabata
Nippon Medical School
3 shared publications - Katsufumi Otsuki
Department of Obstetrics and Gynecology, Showa University Koto Toyosu Hospital, Tokyo, Japan
3 shared publications Kemal Sasaki
Department of Food and Health Sciences, Jissen Women's University, 4-4-1 Osakaue, Hino city, Tokyo 191-8510, Japan
3 shared publications
Latest Publications
- Open Access
- 18 February 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (5) , 873-880
Nationwide status of progestogen treatment to prevent spontaneous preterm birth: A questionnaire survey for childbirth healthcare facilities in Japan
Aim: This study aimed to investigate the current status of progestogen treatment for pregnant women at a high risk for preterm birth (PTB) in childbirth healthcare facilities in Japan.Methods: A web‐based nationwide questionnaire survey regarding progestogen use for prevention of PTB was conducted among childbirth healthcare facilities from 2019 to 2021.Results: Valid responses were obtained from 528 facilities (25.2% of those surveyed), including 155 tertiary perinatal facilities (making up 92.3% of all tertiary perinatal care facilities). In the survey period, progestogen treatment was implemented in 207 facilities (39.2%) for PTB prevention. Regarding types of progestogens, 17α‐hydroxyprogesterone caproate was used in 170 facilities (82.1%), with a low dose (125 mg/week) administered in 62.9% of the facilities to comply with the regulations of the national health insurance system, although 250 mg/week is considered the best dose. Vaginal progesterone was used in 36 facilities (17.4%), although the cost of vaginal progesterone was not covered by health insurance. Of the facilities not administering progestogen treatment, approximately 40% expressed that vaginal progesterone would be their first choice for PTB prevention in daily practice if it would be covered by health insurance in the future.Conclusions: Due to the current regulations of the Japanese health insurance system, 17α‐hydroxyprogesterone caproate, rather than vaginal progesterone, was mainly used for PTB prevention. Despite global evidence supporting vaginal progesterone as the approach with the highest efficacy, only a limited number of facilities have utilized it due to the current drug use regulations in Japan.
- 18 February 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (5) , 873-880
Open AccessNationwide status of progestogen treatment to prevent spontaneous preterm birth: A questionnaire survey for childbirth healthcare facilities in Japan
Aim: This study aimed to investigate the current status of progestogen treatment for pregnant women at a high risk for preterm birth (PTB) in childbirth healthcare facilities in Japan.Methods: A web‐based nationwide questionnaire survey regarding progestogen use for prevention of PTB was conducted among childbirth healthcare facilities from 2019 to 2021.Results: Valid responses were obtained from 528 facilities (25.2% of those surveyed), including 155 tertiary perinatal facilities (making up 92.3% of all tertiary perinatal care facilities). In the survey period, progestogen treatment was implemented in 207 facilities (39.2%) for PTB prevention. Regarding types of progestogens, 17α‐hydroxyprogesterone caproate was used in 170 facilities (82.1%), with a low dose (125 mg/week) administered in 62.9% of the facilities to comply with the regulations of the national health insurance system, although 250 mg/week is considered the best dose. Vaginal progesterone was used in 36 facilities (17.4%), although the cost of vaginal progesterone was not covered by health insurance. Of the facilities not administering progestogen treatment, approximately 40% expressed that vaginal progesterone would be their first choice for PTB prevention in daily practice if it would be covered by health insurance in the future.Conclusions: Due to the current regulations of the Japanese health insurance system, 17α‐hydroxyprogesterone caproate, rather than vaginal progesterone, was mainly used for PTB prevention. Despite global evidence supporting vaginal progesterone as the approach with the highest efficacy, only a limited number of facilities have utilized it due to the current drug use regulations in Japan.
- 27 October 2021
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (1) , 271-274
Vaginal pessary sharpens uterocervical angle in uterine prolapse during pregnancy. A case report
A 37‐year‐old multiparous woman complained of uterine prolapse at 14 weeks of gestation. A silicone ring‐shaped middle‐size vaginal pessary (# 62 mm) was placed into the vagina to reduce prolapsed uterus. Because the cervical length became shortened at 25 weeks of gestation, we decided to start intramuscular administration of progesterone (250 mg) weekly. At 33 weeks of gestation, she complained of the vaginal pessary spontaneous falling out, so we inserted a vaginal pessary of the same size again. The uterocervical angle became acute, going from 100° to 60° after placing the vaginal pessary into the vagina. We took the vaginal pessary out at 37 weeks of gestation. The patient gave birth at 39 weeks by spontaneous vaginal delivery to a healthy baby. A vaginal pessary may help continue a pregnancy via the same mechanism as a cervical pessary, which sharpens the uterocervical angle.
- 27 October 2021
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (1) , 271-274
Vaginal pessary sharpens uterocervical angle in uterine prolapse during pregnancy. A case report
A 37‐year‐old multiparous woman complained of uterine prolapse at 14 weeks of gestation. A silicone ring‐shaped middle‐size vaginal pessary (# 62 mm) was placed into the vagina to reduce prolapsed uterus. Because the cervical length became shortened at 25 weeks of gestation, we decided to start intramuscular administration of progesterone (250 mg) weekly. At 33 weeks of gestation, she complained of the vaginal pessary spontaneous falling out, so we inserted a vaginal pessary of the same size again. The uterocervical angle became acute, going from 100° to 60° after placing the vaginal pessary into the vagina. We took the vaginal pessary out at 37 weeks of gestation. The patient gave birth at 39 weeks by spontaneous vaginal delivery to a healthy baby. A vaginal pessary may help continue a pregnancy via the same mechanism as a cervical pessary, which sharpens the uterocervical angle.
- 5 January 2021
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 47 (3) , 1040-1051
Low placental growth factor levels and high soluble endoglin levels at 26–31 weeks of gestation precede light placenta with and without relatively heavy infant, respectively: A retrospective cohort study
Aim: Our aim was to examine whether serum levels of placental growth factor (PlGF) and soluble endoglin (sEng) at 19–25 and 26–31 weeks of gestation were associated with the occurrence of the 9‐block categorization of placenta weight (PW) and fetal/placenta ratio (F/P ratio).Methods: We performed a retrospective cohort study in 1391 women with singleton pregnancy. Serum levels of PlGF and sEng were measured by enzyme immunosorbent assay. A light placenta was defined as PW ZS < −1.28 SD. Based on the PW (light, normal, and heavy) and F/P ratio (relatively heavy, balanced growth, and relatively small), 9‐block categorization were performed. Multivariable logistic regression analyses were performed.Results: Low PlGF at 26–31 weeks was an independent risk factor for the birth of infants belonging to Block A (light placenta and relatively heavy infant), after adjusting for prepregnancy body mass index and serum levels of sEng. High sEng at 26–31 weeks was an independent risk factor for the birth of infants belonging to Block D (light placenta and balanced growth of infant), after adjusting for past history of either preeclampsia or gestational hypertension, high pulsatility index of uterine artery flow velocity waveforms in the second trimester, and serum level of PlGF.Conclusions: Low PlGF levels at 26–31 weeks of gestation may precede a light placenta and relatively heavy infant (Block A), and high sEng levels at 26–31 weeks of gestation may precede a light placenta and balanced growth of infant (Block D).
- 5 January 2021
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 47 (3) , 1040-1051
Low placental growth factor levels and high soluble endoglin levels at 26–31 weeks of gestation precede light placenta with and without relatively heavy infant, respectively: A retrospective cohort study
Aim: Our aim was to examine whether serum levels of placental growth factor (PlGF) and soluble endoglin (sEng) at 19–25 and 26–31 weeks of gestation were associated with the occurrence of the 9‐block categorization of placenta weight (PW) and fetal/placenta ratio (F/P ratio).Methods: We performed a retrospective cohort study in 1391 women with singleton pregnancy. Serum levels of PlGF and sEng were measured by enzyme immunosorbent assay. A light placenta was defined as PW ZS < −1.28 SD. Based on the PW (light, normal, and heavy) and F/P ratio (relatively heavy, balanced growth, and relatively small), 9‐block categorization were performed. Multivariable logistic regression analyses were performed.Results: Low PlGF at 26–31 weeks was an independent risk factor for the birth of infants belonging to Block A (light placenta and relatively heavy infant), after adjusting for prepregnancy body mass index and serum levels of sEng. High sEng at 26–31 weeks was an independent risk factor for the birth of infants belonging to Block D (light placenta and balanced growth of infant), after adjusting for past history of either preeclampsia or gestational hypertension, high pulsatility index of uterine artery flow velocity waveforms in the second trimester, and serum level of PlGF.Conclusions: Low PlGF levels at 26–31 weeks of gestation may precede a light placenta and relatively heavy infant (Block A), and high sEng levels at 26–31 weeks of gestation may precede a light placenta and balanced growth of infant (Block D).
- Open Access
- 1 January 2019
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 16 (4) , 501-506
Intrauterine Fetal and Neonatal Death between Small for Date and Non-Small for Date in Small for Gestational Age Infants
Objective: To demonstrate the differences in intrauterine fetal deaths and neonatal deaths between small for date (SFD) and Non-SFD neonates by applying a novel classification from both Z scores of placental weight (PW) and fetal/placental weight ratio (F/P) to small for gestational age (SGA) neonates.
- 1 January 2019
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 16 (4) , 501-506
Open AccessIntrauterine Fetal and Neonatal Death between Small for Date and Non-Small for Date in Small for Gestational Age Infants
Objective: To demonstrate the differences in intrauterine fetal deaths and neonatal deaths between small for date (SFD) and Non-SFD neonates by applying a novel classification from both Z scores of placental weight (PW) and fetal/placental weight ratio (F/P) to small for gestational age (SGA) neonates.
- Open Access
- 11 September 2018
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 45 (1) , 86-95
Randomized trial of the efficacy of intravaginal ulinastatin administration for the prevention of preterm birth in women with a singleton pregnancy and both cervical shortening and inflammation of lower genital tract
Aim: To assess the preventive effect on preterm birth of intravaginal ulinastatin (urinary trypsin inhibitor; UTI) administration during the mid‐trimester in women with singleton pregnancy and both cervical shortening and lower genital infections.Methods: Pregnant women with a short cervical length < 25 mm between 16 and 26 weeks of gestation and who had been diagnosed with a lower genital infection were randomly assigned for intravaginal UTI administration or placebo. All of the women were screened for infection or inflammation of the lower genital tract, and women with negative results were excluded.Results: Of the 92 patients with a short cervical length who were assessed for eligibility for this study, 86 singleton patients were enrolled. All patients were randomized to one of two treatment groups: patients administered UTI (n = 35) and placebo (n = 35). There were no differences between the two groups in the incidence of preterm delivery before 28, 30, 32, 34 and 37 weeks of gestation and in perinatal outcomes.Conclusion: For women diagnosed with a short cervical length < 25 mm) between 16 and 26 weeks of gestation and lower genital infection, who were at risk of preterm birth, administration of transvaginal UTI with vaginal irrigation showed no apparent benefit. Future research on the efficacy of UTI should evaluate modified modes of UTI application.
- 11 September 2018
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 45 (1) , 86-95
Open AccessRandomized trial of the efficacy of intravaginal ulinastatin administration for the prevention of preterm birth in women with a singleton pregnancy and both cervical shortening and inflammation of lower genital tract
Aim: To assess the preventive effect on preterm birth of intravaginal ulinastatin (urinary trypsin inhibitor; UTI) administration during the mid‐trimester in women with singleton pregnancy and both cervical shortening and lower genital infections.Methods: Pregnant women with a short cervical length < 25 mm between 16 and 26 weeks of gestation and who had been diagnosed with a lower genital infection were randomly assigned for intravaginal UTI administration or placebo. All of the women were screened for infection or inflammation of the lower genital tract, and women with negative results were excluded.Results: Of the 92 patients with a short cervical length who were assessed for eligibility for this study, 86 singleton patients were enrolled. All patients were randomized to one of two treatment groups: patients administered UTI (n = 35) and placebo (n = 35). There were no differences between the two groups in the incidence of preterm delivery before 28, 30, 32, 34 and 37 weeks of gestation and in perinatal outcomes.Conclusion: For women diagnosed with a short cervical length < 25 mm) between 16 and 26 weeks of gestation and lower genital infection, who were at risk of preterm birth, administration of transvaginal UTI with vaginal irrigation showed no apparent benefit. Future research on the efficacy of UTI should evaluate modified modes of UTI application.
- Open Access
- 12 April 2018
- Published by Gavin Publishers in Annals of Case Reports
- Vol. 7 (3)
A Sinusoidal FHR Pattern observed in a Case of Congenital Leukemia Diagnosed after Emergent Cesarean Delivery
- 12 April 2018
- Published by Gavin Publishers in Annals of Case Reports
- Vol. 7 (3)
Open AccessA Sinusoidal FHR Pattern observed in a Case of Congenital Leukemia Diagnosed after Emergent Cesarean Delivery
- Open Access
- 1 January 2018
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 15 (5) , 484-491
Impact of placental weight and fetal/placental weight ratio Z score on fetal growth and the perinatal outcome
Objective: To classify the infants into 9 blocks based on the deviation of both placental weight (PW) and fetal/placental weight ratio (F/P) Z score and compared the incident rate of perinatal death in each of the small for date (SFD) vs. appropriate for date (AFD) vs. heavy for date (HFD) groups.
- 1 January 2018
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 15 (5) , 484-491
Open AccessImpact of placental weight and fetal/placental weight ratio Z score on fetal growth and the perinatal outcome
Objective: To classify the infants into 9 blocks based on the deviation of both placental weight (PW) and fetal/placental weight ratio (F/P) Z score and compared the incident rate of perinatal death in each of the small for date (SFD) vs. appropriate for date (AFD) vs. heavy for date (HFD) groups.
- 7 February 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (5) , 805-811
Impact of risk factors for perinatal events in Japan: Introduction of a newly created perinatal event score
Aim: A cohort study was performed to clarify the influence of risk factors on perinatal events (obstetric complications and/or perinatal deaths).Methods: This cohort study reviewed 395 785 births from 2011 to 2013. Women with singleton pregnancies delivered after 22 weeks of gestation were included. The OR were determined on multivariate analysis. The perinatal event score (PES) for risk factors, which is the product of the OR of risk factors for obstetric complications, OR of risk factors for perinatal death, and OR of obstetric complications for perinatal death, was introduced to clarify the impact of each risk combination.Results: There were 20 risk factors such as maternal age and medical complications relating to the 11 obstetric complications, including pregnancy‐induced hypertension and preterm labor. As a result, 77 combinations of risk factors and obstetric complications were found to be significant. Six obstetric complications such as preterm labor and cervical insufficiency were found to be related to perinatal death. Two factors were found to be directly related to perinatal death: age >40 years old (OR, 1.24; 95%CI: 1.11–1.39) and essential hypertension (OR, 1.56; 95%CI: 1.19–2.05). As a result, PES ranged from 1.07 (primipara for premature rupture of membrane) to 40.1 (essential hypertension for placental abruption), and high PES (≥8) was identified in 21 combinations of risk factors and obstetric complications.Conclusion: This newly created score for perinatal events, PES, can be used as an indicator of the impact of risk factors on perinatal events.
- 7 February 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (5) , 805-811
Impact of risk factors for perinatal events in Japan: Introduction of a newly created perinatal event score
Aim: A cohort study was performed to clarify the influence of risk factors on perinatal events (obstetric complications and/or perinatal deaths).Methods: This cohort study reviewed 395 785 births from 2011 to 2013. Women with singleton pregnancies delivered after 22 weeks of gestation were included. The OR were determined on multivariate analysis. The perinatal event score (PES) for risk factors, which is the product of the OR of risk factors for obstetric complications, OR of risk factors for perinatal death, and OR of obstetric complications for perinatal death, was introduced to clarify the impact of each risk combination.Results: There were 20 risk factors such as maternal age and medical complications relating to the 11 obstetric complications, including pregnancy‐induced hypertension and preterm labor. As a result, 77 combinations of risk factors and obstetric complications were found to be significant. Six obstetric complications such as preterm labor and cervical insufficiency were found to be related to perinatal death. Two factors were found to be directly related to perinatal death: age >40 years old (OR, 1.24; 95%CI: 1.11–1.39) and essential hypertension (OR, 1.56; 95%CI: 1.19–2.05). As a result, PES ranged from 1.07 (primipara for premature rupture of membrane) to 40.1 (essential hypertension for placental abruption), and high PES (≥8) was identified in 21 combinations of risk factors and obstetric complications.Conclusion: This newly created score for perinatal events, PES, can be used as an indicator of the impact of risk factors on perinatal events.
- 9 December 2016
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (1) , 100-105
Exploratory analysis of textual data from the Mother and Child Handbook using a text mining method (II): Monthly changes in the words recorded by mothers
Aim The aim of the study was to examine the possibility of converting subjective textual data written in the free column space of the Mother and Child Handbook (MCH) into objective information using text mining and to compare any monthly changes in the words written by the mothers. Methods Pregnant women without complications (n = 60) were divided into two groups according to State–Trait Anxiety Inventory grade: low trait anxiety (group I, n = 39) and high trait anxiety (group II, n = 21). Exploratory analysis of the textual data from the MCH was conducted by text mining using the Word Miner software program. Using 1203 structural elements extracted after processing, a comparison of monthly changes in the words used in the mothers' comments was made between the two groups. The data was mainly analyzed by a correspondence analysis. Results The structural elements in groups I and II were divided into seven and six clusters, respectively, by cluster analysis. Correspondence analysis revealed clear monthly changes in the words used in the mothers' comments as the pregnancy progressed in group I, whereas the association was not clear in group II. Conclusion The text mining method was useful for exploratory analysis of the textual data obtained from pregnant women, and the monthly change in the words used in the mothers' comments as pregnancy progressed differed according to their degree of unease.
- 9 December 2016
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (1) , 100-105
Exploratory analysis of textual data from the Mother and Child Handbook using a text mining method (II): Monthly changes in the words recorded by mothers
Aim The aim of the study was to examine the possibility of converting subjective textual data written in the free column space of the Mother and Child Handbook (MCH) into objective information using text mining and to compare any monthly changes in the words written by the mothers. Methods Pregnant women without complications (n = 60) were divided into two groups according to State–Trait Anxiety Inventory grade: low trait anxiety (group I, n = 39) and high trait anxiety (group II, n = 21). Exploratory analysis of the textual data from the MCH was conducted by text mining using the Word Miner software program. Using 1203 structural elements extracted after processing, a comparison of monthly changes in the words used in the mothers' comments was made between the two groups. The data was mainly analyzed by a correspondence analysis. Results The structural elements in groups I and II were divided into seven and six clusters, respectively, by cluster analysis. Correspondence analysis revealed clear monthly changes in the words used in the mothers' comments as the pregnancy progressed in group I, whereas the association was not clear in group II. Conclusion The text mining method was useful for exploratory analysis of the textual data obtained from pregnant women, and the monthly change in the words used in the mothers' comments as pregnancy progressed differed according to their degree of unease.
- 3 May 2016
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 41 (2) , 145-151
Improving the Accuracy of Diagnosing Placenta Previa on Transvaginal Ultrasound by Distinguishing between the Uterine Isthmus and Cervix: A Prospective Multicenter Observational Study
Objective: To clarify whether distinguishing between the uterine isthmus and cervix can improve the accuracy of diagnosing placenta previa at term. Methods: A multicenter prospective observational study was conducted among pregnant women with suspected placenta previa at 20-24 weeks' gestation. Subjects were divided into the open isthmus group and closed isthmus group. The accuracy of diagnosing placenta previa at term was compared between the 2 groups. Results: We screened 9,341 patients, and 53 (0.6%) met the inclusion criteria. Nineteen cases with an open isthmus and 34 with a closed isthmus were followed. The accuracy for diagnosing placenta previa or a low-lying placenta at term was 94.7% in the open isthmus group and 26.5% in the closed isthmus group (p < 0.001). Elective or emergency Cesarean section was required in 100% of cases in the open isthmus group and 20.6% in the closed isthmus group (p < 0.001). Conclusion: A high prediction rate of placenta previa was obtained by using transvaginal ultrasound at 20-24 weeks' gestation after the isthmus opened by carefully distinguishing between the cervix and isthmus.
- 3 May 2016
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 41 (2) , 145-151
Improving the Accuracy of Diagnosing Placenta Previa on Transvaginal Ultrasound by Distinguishing between the Uterine Isthmus and Cervix: A Prospective Multicenter Observational Study
Objective: To clarify whether distinguishing between the uterine isthmus and cervix can improve the accuracy of diagnosing placenta previa at term. Methods: A multicenter prospective observational study was conducted among pregnant women with suspected placenta previa at 20-24 weeks' gestation. Subjects were divided into the open isthmus group and closed isthmus group. The accuracy of diagnosing placenta previa at term was compared between the 2 groups. Results: We screened 9,341 patients, and 53 (0.6%) met the inclusion criteria. Nineteen cases with an open isthmus and 34 with a closed isthmus were followed. The accuracy for diagnosing placenta previa or a low-lying placenta at term was 94.7% in the open isthmus group and 26.5% in the closed isthmus group (p < 0.001). Elective or emergency Cesarean section was required in 100% of cases in the open isthmus group and 20.6% in the closed isthmus group (p < 0.001). Conclusion: A high prediction rate of placenta previa was obtained by using transvaginal ultrasound at 20-24 weeks' gestation after the isthmus opened by carefully distinguishing between the cervix and isthmus.